SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001102624-14-000264
Filing Date
2014-02-20
Accepted
2014-02-20 08:32:23
Documents
2
Period of Report
2014-02-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 THERAVANCE, INC. 8K theravance8k.htm 8-K 5051
2 THERAVANCE, INC. PRESS RELEASE theravanceinc.htm EX-99 12029
  Complete submission text file 0001102624-14-000264.txt   18247
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 14627906
SIC: 2834 Pharmaceutical Preparations